Skip to content
The Kids Research Institute Australia logo
Donate

Search

Showing results for "early lung health"

Folate success helps Aboriginal kids

More than 30 years of research into the links between folate and neural tube defects has paid off for The Kids Research Institute Australia researcher Professor Carol Bower.

The good oil on immunisation

As a new parent or parent-to-be, you will be faced with many important decisions about your health and the health of your child, including immunisation.

AGAR Kids

Bacteraemia is associated with significant morbidity and mortality in children and adults, more frequently affecting neonates, Indigenous children and children admitted to hospital.

Development of new preclinical models of childhood leukaemia

Sébastien Laurence Rishi S. Malinge Cheung Kotecha PhD BPharm (Hons) MBA PhD MB ChB (Hons) MRCPCH FRACP PhD Laboratory Head, Translational Genomics

Novel therapeutics approaches for infants with high-risk infant acute lymphoblastic leukaemia

Rishi S. Laurence Sébastien Kotecha Cheung Malinge MB ChB (Hons) MRCPCH FRACP PhD BPharm (Hons) MBA PhD PhD Co-Head, Leukaemia Translational Research

Covid Vaccination Statement

Re: Recommendations from the Diabetes and Endocrinology Department at Perth Children’s Hospital and the Children’s Diabetes Centre at The Kids Research Institute Australia regarding COVID-19 vaccination for children with diabetes

Looking at the Big Food Picture For T1D

Kids with diabetes should think beyond just carbs, according to The Kids Research Institute Australia senior dietitian Dr Amelia Harray.

Where's the meat? And what's it doing to my HbA1c?

Patients require on average about 50 per cent more insulin with a high protein meal than with a low protein meal. A study conducted by the Children's Diabetes Centre used an insulin clamp technique to determine insulin requirements to maintain euglycaemia across the different meals.

Perspectives on the origin and therapeutic opportunities in Down syndrome-associated leukemia

It is now well accepted that germline or de novo genetic alterations predispose to cancer development, especially during childhood. Among them, constitutive trisomy 21, also known as Down syndrome (DS), has been shown to predispose to acute leukemia affecting both the myeloid (ML-DS) and lymphoid (DS-ALL) lineages. ML-DS is associated with a good prognosis compared to children without DS, due in part to a higher sensitivity to conventional chemotherapy.